RN
RenaissanceRe Holdings Ltd.
RNR-PF · NYSE
$19.76 -0.45% (-$0.09)
1M -5.18%
Market Cap $6.22B
P/E Ratio 2.36x
Div. Yield 7.23%
ROE 22.68%
Bulios Fair Price
$24.59
24.4% upside
Current Price
$19.76
Undervalued Fair Value Overvalued
According to Bulios Fair Price, RNR-PF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
100 /100
Cheap P/S 0.58x
P/B 0.53x
P/E 2.36x
Growth
100 /100
Growing Book val. growth 29.66%
Rev. growth 36.17%
FCF growth N/A
Profitability
99 /100
Strong Op. margin 38.77%
Net margin 24.71%
FCF margin N/A
Quality
100 /100
Excellent ROA 4.77%
Asset turnover 0.19x
ROE 22.68%
Debt
100 /100
Low Current ratio 1.76x
Int. coverage N/A
Net debt/EBITDA N/A
Stability
14 /100
Unstable Rev. volatility 36.58%
EPS volatility 174.33%
Profitable years 3
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RNR-PF
Online
Sector
Financial Services
Industry
Insurance - Reinsurance
CEO
Kevin J. O'Donnell
Employees
1,040
Headquarters
Pembroke
Upcoming events
03 NOV
Earnings
Upcoming earnings report